Fibrinogen administration in prehospital trauma
This report considers if Fibrinogen Concentrate (FC) is a reasonable alternative to allogeneic products in the prehospital setting by examining the literature regarding patient mortality, intensive care unit (ICU) length of stay, safety, need for additional blood products, storage, administration and costs.
Key points from the report:
- Current published evidence is low quality
- Suggests FC in hospital setting is safe and effective
- Logistic advantages for FC with storage, preparation and more rapid administration
In the absence of allogenic products, FC could be considered as a reasonable prehospital alternative. This is best conducted under clinical trial conditions.
For more information please contact:
NSW Institute of Trauma and Injury Management
+61 2 9464 4663